Subplate neurons are among the earliest-generated neurons of developing cerebral cortex and form the deepest layer below the developing cortical plate (Allendoerfer and Shatz, 1994) . They are the first cortical neurons to differentiate and become incorporated into functional neuronal circuits, where they are needed for the establishment of thalamocortical connections (Friauf et al., 1990; Ghosh et al., 1990; Ghosh and Shatz, 1993) . However, unlike later-generated cortical neurons, large numbers of subplate neurons undergo programmed cell death during early postnatal development (Allendoerfer and Shatz, 1994; Spreafico et al., 1995; Price et al., 1997) . This raises the question of how a mature population of CNS neurons that is fully integrated into a functioning circuit are selectively eliminated, and conversely, what signal transduction pathways control their survival.
Neuronal survival throughout the peripheral nervous system (PNS) is primarily controlled by neurotrophins interacting with two types of neurotrophin receptors: the ligand-selective Trk tyrosine kinases and the nonselective p75 neurotrophin receptor (p75NTR) (Barbacid, 1995; Conover and Yancopoulos, 1997; Chao et al., 1998) . Trk receptors play a critical role in promoting the survival of many PNS neurons via activation of their tyrosine kinase domains. In contrast, the role of p75NTR in neuronal survival is cell-type dependent. From studies of knock-out mice, p75NTR is known to be required for survival of nociceptive sensory neurons, although it mediates naturally occurring cell death of sympathetic and certain motor neurons (Lee et al., 1992; Bamji et al., 1998; Brennan et al., 1999; Frade and Barde, 1999) . In vitro, p75NTR has been found to mediate neuronal survival by facilitating Trk signaling at low neurotrophin concentrations (Davies et al., 1993; Lee et al., 1994) . Death, on the other hand, is thought to result from p75NTR signaling in the absence of Trk activation (Carter and Lewin, 1997; Dechant and Barde, 1997; Yoon et al., 1998) . This leads to ceramide production, which in turn activates an apoptotic signaling cascade (Casaccia-Bonnefil et al., 1996; Hannun, 1996) .
Analysis of mice deficient in neurotrophins or their receptors also argues for neurotrophin-dependent survival of certain populations of cerebral cortical neurons (Minichiello and Klein, 1996; Alcántara et al., 1997; Chen et al., 1997; Fagan et al., 1997; Peterson et al., 1999) . However, because neurotrophins also regulate axon outgrowth, it is unclear from these in vivo studies whether the neurotrophins and their receptors promote survival by acting directly on the neurons of interest, or whether they indirectly promote survival by affecting other cell types or even target innervation. p75NTR, as well as TrkB, is expressed by subplate neurons (Allendoerfer et al., 1990; Cabelli et al., 1996) . Whereas TrkB is also expressed by neurons of all other cortical layers, p75NTR expression within developing neocortex is highly restricted to the subplate (Koh and Loy, 1989; Allendoerfer et al., 1990; Meinecke and Rakic, 1993) . Given the link between p75NTR and cell death in the PNS (Carter and Lewin, 1997; Dechant and Barde, 1997; Chao et al., 1998) , we hypothesized that the selective loss of subplate neurons could be explained by the restricted expression of p75NTR and activation of its associated apoptotic signaling pathways. To study the role of p75NTR and its associated signal transduction pathways on subplate neuron survival, we used immunopanning techniques to purify these neurons. This novel purification of subplate neurons allowed us to determine the direct effect of p75NTR and its signaling pathways on their survival in a less complicated cellular environment. Surprisingly, we found that ligand binding to p75NTR promotes survival, not death, of cultured subplate neurons and that this survival is blocked by drugs that inhibit the synthesis of ceramide, identified previously as an apoptotic signal.
MATERIALS AND METHODS
Subplate neuron purification. All reagents were purchased from Sigma (St. L ouis, MO) unless otherwise noted. The immunopanning plate was coated with goat anti-mouse (Jackson ImmunoResearch, West Grove, PA) as described by Barres et al. (1988) and then coated with 0.55 g /cm 2 anti-p75N TR monoclonal antibody 192 (mAb 192) in HBSS (Mediatech Inc., Ormond Beach, FL) with 10% fetal bovine serum. mAb 192 (Chandler et al., 1984) was the generous gift of Eric Shooter (Stanford University, Stanford, CA). Brains from embryonic day 17 (E17) (day of breeding is E0) L ong-Evans rats (Simonsen Laboratories, Gilroy, CA) were dissected on ice in HBSS. Meninges were removed, and dorsolateral caudal neocortex was digested in 23 U/ml papain (Worthington, Freehold, NJ) and 10 g /ml DNase I as described by Huettner and Baughman (1986) . Digestion was stopped with 10 g /ml antipain. Dissociated cells were centrif uged through a 15%/60% Percoll (Amersham Pharmacia Biotech, Uppsala, Sweden) step gradient for 5 min at 400 ϫ g, and cells were collected at the 15%/60% Percoll interface. After a 30 min recovery, cells were applied to the mAb 192-coated immunopanning plate (ϳ1 ϫ 10 8 cells per plate) and allowed to attach for 20 min at 4°C. After four washes to remove unbound cells, the bound cells were removed by digestion with saline -0.05% trypsin -versene (University of C alifornia, San Francisco C ell Culture Facility) for 5 min. Resultant cells were washed and cultured in Neurobasal medium with B-27 additives (Life Technologies, Gaithersburg, MD) and penicillin -streptomycin on tissue culture plastic coated with 1 mg /ml poly-ornithine and 15 g /ml fibronectin (Becton Dickinson, Mountain View, CA) in calcium, magnesiumfree-PBS.
In situ hybridization. In situ hybridization was performed as described by Corriveau et al. (1998) , using probes specific for rodent p75N TR, TrkA, TrkB, and TrkC. Murine clones were obtained from either cDNA produced from RNA from embryonic (E18) mouse spinal cord or neonatal mouse brain. The PCR primers used for amplification of mouse fragments were designed from published sequences and were as follows: p75N TR, 5Ј-TGACCAC TGTGATGGGCAG-3Ј and 5Ј-GCC TCGT-GGGTAAAGGAGTC -3Ј; TrkA, 5Ј-C TAGGCGGTC TGGTGAC -TTC-3Ј and 5Ј-CTTCCACAGAGTCATTGGGC-3Ј; TrkB, 5Ј-CGGCA-CATAAATTTCACACG-3Ј and 5Ј-ACAGTGAATGGAATGCACCA-3Ј; and TrkC, 5Ј-CGAAGACAATGGTTTCACCC TGAC -3Ј and 5Ј-CAACTGCTATGGACACCCCAAAAG-3Ј. Amplified fragments were gel purified and cloned into pBSII-KS vector. Plasmids were sequenced to verify the product. Antisense riboprobes produced from these cDNAs of p75NTR and the Trks hybridize to the extracellular regions of each of these receptors (Radeke et al., 1987; Klein et al., 1989; Kaplan et al., 1991; Lamballe et al., 1991) . Sense controls showed no hybridization signal.
BrdU birth dating. Animals were used in accordance with University of C alifornia guidelines for animal usage. L ong-Evans rats, 12 or 15 d pregnant, were injected intraperitoneally with 35 mg / kg 5-bromo-2-deoxyuridine (BrdU). To detect BrdU in situ, cryostat sections were microwaved in 0.05 M citrate, pH 5.0, for 14 min and incubated with 100U/ml E xo III and anti-BrdU monoclonal I U-4 (C altag, South San Francisco, CA). Bound antibody was detected with HRP-conjugated anti-mouse (Jackson ImmunoResearch), followed by FI TC -tyramide (N EN, Boston, M A). Sections were counterstained with bisbenzimide. To detect BrdU in culture, cells grown for 15 hr were fixed in 95% ethanol -5% acetic acid at Ϫ20°C for 15 min and incubated with 2N HC l for 40 min at room temperature. BrdU immunohistochemistry was done according to standard protocols using I U-4 and C y3-conjugated donkey anti-mouse (1:200; Jackson ImmunoResearch) with bisbenzimide as a nuclear counterstain. Percentage of BrdU-labeled cells was determined by counting Ͼ200 cells from randomly chosen fields from three separate preparations and dividing by the total number of bisbenzimide-labeled nuclei. Results are mean Ϯ SEM.
Immunohistochemistr y. Bound and unbound cells were cultured for either 1 or 15 hr and fixed with 95% ethanol -5% acetic acid at Ϫ20°C for 15 min. C ells were stained by standard immunofluorescent staining protocols using anti-Tau sera (catalog #T6402; Sigma), anti-vimentin (clone V9; Boehringer Mannheim, Mannheim, Germany), anti-nestin (catalog #M AB353; Chemicon, Temecula, CA), or anti-p75N TR (catalog #G3231; Promega, Madison, W I). For visualization, secondary antibodies used included C y3-conjugated donkey anti-mouse or anti-rabbit (1:200; Jackson ImmunoResearch) or Alexa488-conjugated anti-mouse (1:200; Molecular Probes, Eugene, OR). Bisbenzimide counterstain was used to count the total number of cells.
Survival assays. Subplate neurons were cultured in 48 well dishes for 3-4 d in Neurobasal medium and B-27 additives with or without added neurotrophins: mouse NGF, recombinant human BDN F, and recombinant human neurotrophin 3 (N T3) (Alomone Labs, Jerusalem, Israel). Survival was measured using the Live/ Dead Assay (Molecular Probes). T wo counts of Ͼ100 cells each were made from random fields of each well. Each experiment was done in duplicate and repeated at least three times, and the results were averaged. All reagents added to the cultures were added at the time of plating for the extent of the experiment. Reagents used were as follows: K252a (Alomone Labs) at 200 nM, anti-p75N TR FAbs antibodies and normal rabbit FAbs at 200 g /ml, excess NGF at 3 g /ml, f umonisin B1 at 10 M (Biomol, Plymouth Meeting, PA), myriocin at 50 nM (Biomol), and C -6 sphingomyelin (Matreya Inc., Pleasant Gap, PA) at 0.3 M. Function-blocking antip75N TR antisera (Weskamp and Reichardt, 1991) was the generous gift of L ouis Reichardt (University of C alifornia, San Francisco). IgG was purified from this antisera with protein G Sepharose (Amersham Pharmacia Biotech). FAb fragments were prepared using immobilized papain (Pierce, Rockford, IL). For treatment with FAbs, sphingolipids, and sphingolipid synthesis inhibitors, neurotrophins were used at 30 ng /ml. For NGF competition, BDN F was used at 3 ng /ml.
Detection of phosphor ylated Trk and mitogen-activated protein k inase. Subplate neurons cultured for 24 hr were treated with 100 ng /ml neurotrophin for 40 min for detection of phosphorylated mitogen-activated protein kinase (M APK) or for 5 min for detection of phosphorylated Trk. To block Trk signaling, neurons were incubated with 200 nM K252a for 1 hr before addition of neurotrophin. Equal numbers of neurons were extracted with 30 l of extraction buffer (20 mM Tris, pH 7.5, 250 mM NaC l, 0.5% Triton X-100, 3 mM EGTA, 3 mM EDTA, 20 mM ␤-glycerophosphate, 0.1 mM NaVO 4 , 50 mM NaF, 5 g /ml chymostatin, 5 g /ml leupeptin, 5 g /ml antipain and 5 g /ml pepstatin, and 1 mM PMSF) and scraped off the culture dish. E xtracts were spun at 10,000 rpm for 10 min. Equal amounts of supernatant were analyzed by SDS-PAGE and standard immunoblotting techniques. Nitrocellulose blots (Schleicher & Schuell, Dassel, Germany) were blocked with Superblotto (Pierce) and incubated with a 1:5000 dilution of anti-active M APK (catalog #V6671; Promega) or with a 1:750 dilution of anti-phosphoTrkA (T yr490) [(catalog #9141S; New England Biolabs, Beverly, M A) this antibody cross-reacts with phosphorylated TrkB and TrkC]. The secondary antibody was 1:10,000 HRP-conjugated donkey anti-rabbit (Jackson ImmunoResearch). Blots were visualized by enhanced chemiluminescence (N EN).
RESULTS

Subplate neurons express p75NTR and Trks
Subplate-restricted expression of p75NTR, as well as coexpression of Trks, was revealed by in situ hybridization using Trk and p75NTR-specific [
35 S]-riboprobes on sections of E17 rat cerebral cortex (Fig. 1) . Subplate neurons were labeled with a pulse of BrdU at E12, when they are undergoing their final round of cell division. Because subplate and marginal zone neurons are the only cortical neurons that become postmitotic on E12 in rat, they are the only cells subsequently heavily labeled with BrdU ( Fig. 1 ) (Bayer and Altman, 1990) . Note that, because subplate neurons in rat are generated over a period of several days (E12-E15), only a fraction of them are heavily labeled by a single injection of BrdU. p75NTR expression is restricted to the meninges and the subplate zone and colocalizes with the region of heavily BrdUlabeled subplate neurons. On the other hand, TrkB and TrkC are expressed throughout the cortical plate, the subplate, and the ventricular zone. In contrast, TrkA is not detected in cortex at this age. Thus, whereas TrkB and TrkC are expressed by many postmitotic neurons, embryonic expression of p75NTR is restricted to those neurons known to later undergo programmed cell death.
Purification and identification of subplate neurons in culture
To evaluate the function of p75NTR in subplate neurons, they were immunopurified based on their restricted expression of p75NTR and then cultured under serum-free conditions at low density in vitro. This approach permits the study of the direct function of p75NTR, as well as the analysis of p75NTR signaling pathways in the absence of other cell types. The majority of immunopurified cells have a pyramidal morphology, typical of subplate neurons in vivo (Friauf et al., 1990; Allendoerfer and Shatz, 1994) , and readily extend processes on a fibronectin substrate in vitro (Fig. 2a) . BrdU birth dating and immunocytochemistry for neuronal and non-neuronal cell markers confirm the identity of the panned cells as subplate neurons. A pulse of BrdU given at E12, a time when only subplate and marginal zone neurons are generated (Bayer and Altman, 1990) , labels 33% of the immunopurified cells (recall that a pulse of BrdU will only label a fraction of all subplate neurons), whereas only 10% of the unbound cells are BrdU labeled (Fig. 2b) . Conversely, a pulse label of BrdU at E15, a time when most neurons being born are destined for layer VI rather than the subplate (Bayer and Altman, 1990) , labels only 16% of the immunopurified cells versus 45% of the unbound cells. Thus, the birth date of the purified cells coincides with that of subplate neurons. The panned cells were also characterized by immunostaining with antibodies to intermediate filaments: Tau, vimentin, and nestin. In E17 cortex, these are markers for neurons, radial glia and endothelial cells, or neuroblasts, respectively (Schnitzer et al., 1981; Bignami et al., 1982; Ferreira et al., 1987; Lendahl et al., 1990) . Whereas the unbound cells consist of approximately equal amounts of Tau-, vimentin-, and nestin-positive cells, the immunopurified cells are 90% neuronal based on Tau staining (Fig. 2c) . The remaining 10% are mostly vimentin-positive cells that likely represent blood vessel endothelial cells, because p75NTR antibodies recognize blood vessels as well as subplate neurons in embryonic cortex (Koh and Loy, 1989; Allendoerfer et al., 1990) . However, these and the Ͻ1% contaminating nestin-positive cells are easily distinguished from the neurons by morphology, and most are not viable in the serum-free culture medium used here (data not shown). p75NTR expression, although at low levels by immunostaining, was also found on almost all of the panned cells in culture (Fig. 2c) . Based on their neuronal phenotype, birth date, and expression of p75NTR, 90% of the immunopurified cells are subplate neurons. This represents the first purification of a lamina-specific population of neocortical neurons.
p75NTR promotes survival of cultured subplate neurons
The function of p75NTR was assayed in subplate neurons cultured in the presence or absence of exogenous neurotrophins. In the absence of exogenous neurotrophins, 60 -85% of subplate neurons die after 4 d in culture. As shown below, this loss likely reflects the lack of trophic factors. However, an alternative possibility is that p75NTR is aggregated and consequently activated by the antibody used in the panning procedure, thereby resulting in the slow cell death seen in culture. We consider this possibility highly unlikely because the monoclonal antibody used in panning [mAb 192 (Chandler et al., 1984) ] does not affect survival of subplate neurons when either added to the culture medium or used as a substrate for cell attachment (data not shown). Addition of exogenous BDNF increases survival approximately twofold over control cultures (Fig. 3 a, b) . Survival was dose dependent and required a concentration of 0.3 ng/ml for maximal response (Fig. 3b) . To test directly the role of p75NTR in BDNF-mediated survival, FAb fragments of a polyclonal antibody to the extracellular domain of p75NTR were used to block BDNF binding (Weskamp and Reichardt, 1991) . Anti-p75NTR FAb fragments completely inhibit BDNF-mediated survival but have no effect on the basal survival of subplate neurons (Fig. 3a) . Normal rabbit FAbs are without effect. Thus, BDNF binding to p75NTR is necessary for BDNF-mediated survival.
Because p75NTR is known to bind all neurotrophins with similar affinity , the effects of NGF and NT3 on subplate neuron survival were also examined. NT3, like BDNF, increases subplate neuron survival approximately twofold (Fig.  3c) . NGF, on the other hand, has no significant effect on subplate neuron survival. However, when used in excess, NGF blocks BDNF-dependent survival (Fig. 3d) . This observation suggests that NGF competes with BDNF for binding to p75NTR and is consistent with the model that BDNF binding to p75NTR is required for BDNF-dependent survival. Importantly, NGF does not cause significant cell death, despite the fact that subplate neurons do not express the Trk receptor for NGF, TrkA. These observations differ significantly from results in sympathetic neurons and oligodendrocytes, in which p75NTR signaling promotes cell death in the absence of activated TrkA receptors (Bamji et al., 1998; Yoon et al., 1998) . Coaddition of saturating amounts of both BDNF and NT3 does not increase subplate neuron survival above that with either factor alone (Fig. 3c) . Therefore, BDNF and NT3 must act on the same population of neurons, possibly via similar mechanisms. 
Signaling through Trk kinases is not required or sufficient for BDNF-dependent survival
Because p75NTR binds all three neurotrophins, but NGF by itself is without effect, this data suggests that BDNF-dependent survival of subplate neurons might also require the function of ligand-specific Trk receptors in addition to p75NTR. This hypothesis is supported by the observation that subplate neurons express the Trk receptors for both BDNF and NT3 (TrkB and TrkC, respectively) but not the Trk receptor for NGF TrkA (Fig.  1) . To assess the role of Trk tyrosine kinases in subplate neurons, K252a, which potently inhibits several tyrosine kinases including the Trks (Berg et al., 1992) , was added to subplate neurons in the presence or absence of neurotrophin. Addition of K252a alone increases the background level of subplate neuron survival. A similar increase in survival by K252a has been shown in studies of cultured sensory, striatal, and basal forebrain neurons and likely results from inhibition of other kinases (Borasio, 1990; Glicksman et al., 1995) . However, BDNF and NT3 are still able to further augment survival beyond that of K252a alone (Fig. 4a) .
To confirm that Trk activity is completely blocked by K252a, extracts of subplate neurons were probed with an antibody that recognizes all Trks (A, B, and C) phosphorylated at Y490 Binder et al., 1999) . Because Y490 is autophosphorylated by Trk tyrosine kinases, its phosphorylation state is indicative of Trk activity . As shown in Figure 4b , treatment of subplate neurons with BDNF results in the robust phosphorylation of Trk at Y490 compared with control. However, K252a completely inhibits the BDNF-dependent phosphorylation of Y490. It is, however, possible that undetectable Trk kinase activity is enough to activate downstream signaling pathways. The Trk tyrosine kinases activate several signaling cascades, including one leading to phosphorylation and activation of MAPK (Segal and Greenberg, 1996) . In some types of neurons, including retinal ganglion cells and sympathetic neurons, Trks mediate survival via the activation of this downstream pathway Neurotrophin-mediated survival of subplate neurons is dependent on p75NTR. a, Survival of subplate neurons in the absence or presence of 30 ng/ml exogenous BDNF. Anti-p75NTR FAbs (black bars) or normal rabbit FAbs (white bars) were added and compared with survival in the absence of FAbs (shaded bars). *p Ͻ 0.01 compared with BDNF with no FAbs. b, Dose-response curve for BDNF-dependent survival of subplate neurons. c, Survival of panned subplate neurons in the presence of 100 ng/ml neurotrophins (normalized to neurons grown in the absence of exogenous neurotrophin). *p Ͻ 0.01 compared with control. d, Subplate neurons were cultured with BDNF (3 ng/ml) with (black bars) or without (white bars) excess NGF (3 g/ml). *p ϭ 0.016 compared with BDNF alone. (Meyer-Franke et al., 1998; Bonni et al., 1999; Hetman et al., 1999; Atwal et al., 2000) . To verify that this Trk-specific signaling pathway is also blocked by K252a, subplate extracts were probed with an antibody to phosphorylated, and thus active, MAPK. As shown in Figure 4b , treatment of subplate neurons with BDNF results in phosphorylation of MAPK, and this phosphorylation is completely blocked by K252a. Thus, K252a blocks the BDNFdependent activation of Trk tyrosine kinases (likely TrkB), as well as downstream signaling pathways. This data argues that Trk signaling by activation of its tyrosine kinase is not necessary for BDNF-enhanced survival. However, this data does not rule out the possibility that Trk receptors may play a role in subplate neuron survival in a novel, non-kinase-dependent manner.
A model consistent with a role for Trks in subplate neuron survival is that p75NTR acts only to facilitate neurotrophin binding and Trk signaling but does not itself signal. This model is suggested by data in other neurons and cell lines that show that p75NTR associates with all three Trks (Bibel et al., 1999) , and in the case of NGF, facilitates TrkA signaling at low neurotrophin concentrations (Davies et al., 1993; Lee et al., 1994; Chao et al., 1998) . To test this possibility in subplate neurons, we treated subplate neurons with BDNF in the presence of high concentrations of NGF, which competes with BDNF for binding to p75NTR but not to TrkB (Barbacid, 1995) . This excess quantity of NGF does not affect neuronal survival or MAPK activation by itself (Figs. 3d, 4c) . However, although excess NGF blocks BDNF-dependent survival of subplate neurons (Fig. 3d) , it does not affect the BDNF-dependent activation of MAPK, as shown in Figure 4c . Thus, the activation of Trk signaling pathways does not require p75NTR, nor are these pathways sufficient to increase subplate neuron survival. Together, these data argue against a role for Trks and instead strongly argue for the importance of p75NTR signaling pathways.
A sphingolipid signaling pathway is required for subplate neuron survival
Because p75NTR is required for BDNF-mediated subplate neuron survival, known p75NTR signaling pathways were examined in these neurons. p75NTR activates sphingomyelinase, c-Jun N-terminal kinase (JNK), and nuclear translocation of the transcription factor NFB in other cell types (Dobrowsky et al., 1994; Carter et al., 1996; Casaccia-Bonnefil et al., 1996) . Whereas nuclear NFB binding activity is not detectably affected by treatment of subplate neurons with BDNF, there is a marked increase in JNK phosphorylation by BDNF but not NGF (data not shown). However, BDNF-dependent phosphorylation of JNK is not affected by blocking binding to p75NTR (data not shown). Thus, NFB and JNKs do not appear to play a central role in p75NTR-mediated survival.
In certain cell types, ligand binding to p75NTR activates sphingomyelinase, an enzyme that converts sphingomyelin to ceramide (Dobrowsky et al., 1994 (Dobrowsky et al., , 1995 . Ceramide, in turn, can mediate apoptosis (Casaccia-Bonnefil et al., 1996; Hannun, 1996) . Activation of sphingomyelinase is mediated by p75NTR but not Trk receptors (Dobrowsky et al., 1995) . To test the role of this signal transduction pathway in BDNF-mediated subplate neuron survival, we inhibited the synthesis of both ceramide and sphingomyelin. Synthesis of all sphingolipids, including sphingomyelin and ceramide, begins with the conversion of serine to sphinganine and then to N-acetylsphinganine. These biosynthetic steps are inhibited by myriocin and the fungal mycotoxin, fumonisin B1, respectively (Merrill et al., 1993; Miyake et al., 1995) . Treatment of cerebellar neurons with fumonisin B1 reduces sphingomyelin content drastically (Merrill et al., 1993) .
To examine whether regulation of sphingolipid signaling is involved in p75NTR-mediated survival, subplate neurons were grown in either fumonisin or myriocin in the presence or absence of BDNF. Treatment of subplate neurons with fumonisin B1 or myriocin completely abolishes the ability of BDNF to support survival (Fig. 5a ) but does not affect the basal level of survival. Thus, blocking sphingolipid synthesis is not toxic in and of itself. To confirm the specificity of the fumonisin blockade of sphingolipid synthesis, exogenous sphingomyelin was added to subplate neurons grown in the presence of fumonisin B1. In fumonisin B1, neither sphingomyelin nor BDNF alone are able to enhance subplate neuron survival. However, coaddition of BDNF and sphingomyelin to fumonisin-treated neurons increases their survival to levels comparable with that of BDNF in the absence of fumonisin. (Fig. 5b) .
To verify that BDNF-dependent survival is not limited by the concentration of sphingomyelin, subplate neurons were grown in fumonisin with increasing concentrations of exogenous sphingomyelin. As shown in Figure 5c , sphingomyelin does not affect the survival of subplate neurons at concentrations as high as 3 M but at 10 M becomes toxic. In this same concentration range, sphingomyelin rescue of BDNF-dependent survival is maximal at 0.3 and 1 M (Fig. 5c ). Survival at these concentrations is equivalent to the level of BDNF-dependent survival in the absence of fumonisin or exogenous sphingomyelin (dotted line). Thus, the sphingomyelin concentration is not limiting for BDNFdependent survival. In addition, increased sphingomyelin levels do not directly promote subplate neuron survival but are a necessary substrate for BDNF-mediated survival, likely through the regulation of sphingomyelinase.
These results provide additional evidence that a p75NTR-specific signaling pathway is necessary for BDNF-dependent survival and provide an unusual example in which p75NTR signaling through the sphingolipid pathway supports neuronal survival, not death.
DISCUSSION
The results of this study show that ligand binding to p75NTR can promote survival, not death, of a neocortical neuronal population via a sphingolipid signaling pathway. This is surprising in the context of well known examples of neuronal death triggered by ligand-dependent p75NTR activation of ceramide signaling.
Research into the role of p75NTR in neuronal survival has provided contradictory results depending on the type of neurons examined. Studies of mice carrying a gene deletion of p75NTR reveal that it is necessary for survival of sensory and basal forebrain cholinergic neurons, although, conversely, it is necessary for naturally occurring cell death in sympathetic, motor, and retinal neurons (Lee et al., 1992; Bamji et al., 1998; Brennan et al., 1999; Frade and Barde, 1999; Peterson et al., 1999) . However, because both neuronal and non-neuronal cells express p75NTR, it is unclear from these studies, as well as studies of unpurified neurons in vitro, whether or not p75NTR functions in a cellautonomous manner for all of these neuronal populations. Our study is thus novel in that we used a highly purified population of CNS neurons cultured at low density, allowing assessment of the direct role of p75NTR and associated signaling pathways on neuronal survival.
p75NTR signaling is required for BDNF-dependent survival
Although p75NTR-mediated cell death has been linked to the ceramide signaling pathway (Dobrowsky et al., 1994; CasacciaBonnefil et al., 1996) , the mechanism of p75NTR-mediated survival is unclear. One model is that p75NTR indirectly promotes survival by facilitating neurotrophin binding to the Trk receptors (Davies et al., 1993; Lee et al., 1994; Chao et al., 1998) . The Trk receptor tyrosine kinases, and not p75NTR, then transduce the survival signal. Thus, high concentrations of neurotrophin can support survival even in the absence of p75NTR (Davies et al., 1993; Lee et al., 1994) . This mechanism is not consistent with our results in subplate neurons. First, inhibition of Trk phosphorylation with K252a does not inhibit BDNF-dependent survival. Also, the concentration of BDNF used in conjunction with p75NTR FAbs was 30-fold higher than that required to stimulate Trk-dependent survival maximally in the absence of p75NTR (Davies et al., 1993; Lee et al., 1994) . Finally, excess NGF, which competes for binding to p75NTR but not TrkB, blocks BDNFdependent survival but not activation of the Trk-dependent MAPK signaling cascade. Thus, our data strongly support an alternative model that p75NTR directly signals survival in subplate neurons.
A role for p75NTR signaling is further supported by the requirement for sphingolipid synthesis in BDNF-dependent subplate survival. Ligand binding to p75NTR, but not Trk receptors, activates sphingomyelinase, which converts sphingomyelin to ceramide (Dobrowsky et al., 1995) . Ceramide in turn acts as a second messenger that activates apoptotic pathways in some cell types (Casaccia-Bonnefil et al., 1996; Hannun, 1996) . In cells that express both p75NTR and a Trk, coactivation of the high-affinity Trk receptors has been found to suppress p75NTR activation of the ceramide pathway and apoptosis (Dobrowsky et al., 1995; Bamji et al., 1998; Davey and Davies, 1998; Yoon et al., 1998) . By this model, the p75NTR apoptotic pathway is only activated by neurotrophins when the Trk receptor tyrosine kinase is not coactivated.
This model, derived from studies of sensory and sympathetic neurons as well as non-neuronal cells, contrasts with our results in subplate neurons in several important respects. First, inhibition of ceramide synthesis prevents BDNF-dependent survival rather than increasing survival, as would be predicted if ceramide mediates cell death. Second, BDNF-dependent survival is rescued by sphingomyelin, the precursor to ceramide. This indicates that p75NTR regulation of sphingomyelinase is a necessary component of BDNF-dependent survival signaling pathway in subplate neurons. This data also suggest that p75NTR promotes survival, not death, by increasing production of ceramide. Finally, because BDNF activates signaling through a Trk kinase (likely TrkB) in subplate neurons (Fig. 4) , p75NTR regulation of the ceramide pathway does not appear to be suppressed by a coactivated Trk. The fact that ligand binding to p75NTR is linked to survival in subplate neurons but death in other cell types implies that contradictory roles of p75NTR in vivo may reflect differences in downstream responses to ceramide rather than be solely attributable to the presence or absence of particular Trk receptors.
Our data also rule out the possibility that BDNF promotes survival by decreasing ceramide levels resulting from ligandindependent p75NTR signaling. Ligand-independent p75NTR signaling in response to neurotrophin withdrawal leads, in some cell types, to ceramide production and apoptosis (Bredesen and Rabizadeh, 1997) . However, if subplate neurons die from high levels of ceramide resulting from ligand-independent p75NTR signaling, then inhibition of sphingolipid synthesis would be expected to reduce ceramide levels and increase survival. Because survival is not increased by either fumonisin B1 or myriocin, this model is very unlikely. Thus, these observations provide an unusual example in which p75NTR signaling through the sphingolipid pathway supports neuronal survival, not death.
Molecular mechanism of p75NTR signaling
The molecular details of the p75NTR-activated ceramide signaling cascade are currently only partially understood. p75NTR, by analogy to other members of the TNF receptor family to which it belongs, is thought to initiate signal transduction by clustering within the membrane, causing specific adaptor molecules to associate with its cytoplasmic domain (Dechant and Barde, 1997; Kaplan and Miller, 2000) . p75NTR also activates a sphingomyelinase activity in the inner leaflet of the plasma membrane; however, the identity of this sphingomyelinase, as well as how it is coupled to the initial steps in p75NTR signal transduction, is unknown (Dobrowsky et al., 1995) . Once activated, sphingomyelinase hydrolyzes sphingomyelin to ceramide. Ceramide then activates JNK, which is linked to the apoptotic cascade in several types of neuronal cells (Casaccia-Bonnefil et al., 1996; Dechant and Barde, 1997; Borasio et al., 1998; Chao et al., 1998; Maroney et al., 1998; Kaplan and Miller, 2000) . Examination of JNK knock-out mice, however, reveals that, although JNK is necessary for cell death of neuronal cells in the developing spinal cord, it is required for survival of neuronal cells in developing neocortex (Kuan et al., 1999) . This suggests that one difference between the subplate neurons and the peripheral neurons that have been studied is opposite responses to JNK activation. However, although NGF and anti-p75NTR block BDNF-dependent survival, they do not block the activation of JNK in subplate neurons (our unpublished observations). Therefore, although JNK may play a role in facilitating survival, it does not appear to be sufficient.
Other signaling targets for ceramide that have been identified include protein phosphatase 2A, protein phosphatase 1, kinase suppressor of ras (KSR), and PKC (Dobrowsky et al., 1993; Zhang et al., 1997; Chalfant et al., 1999; Wang et al., 1999; Bourbon et al., 2000) . Ceramide activation of KSR modulates the Ras-MAPK pathway in certain non-neuronal cells (Therrien et al., 1996; Sugimoto et al., 1998; Yu et al., 1998) and likely accounts for the p75NTR-dependent activation of MAPK in cerebellar cells (Susen et al., 1999) . Although MAPK promotes neurotrophin-dependent survival of several other types of p75NTR-expressing neurons, including retinal neurons (MeyerFranke et al., 1998; Bonni et al., 1999; Hetman et al., 1999; Atwal et al., 2000) , it is activated by the Trk receptors, not p75NTR . Likewise, MAPK appears to be activated by Trk receptors in subplate neurons as well, because activation of MAPK by BDNF is completely blocked by K252a but not by blocking BDNF binding to p75NTR. Ceramide also directly activates PKC at low concentrations, which correlates with increased survival in the PC12 neuronal cell line (Wang et al., 1999) . In contrast, high concentrations of ceramide (Ͼ2.5 M) inhibit PKC and increase apoptosis of PC12 cells. Overexpression of PKC in these cells enhances survival at high concentrations of ceramide, suggesting that PKC plays a direct role in survival. Interestingly, this biphasic response to ceramide, with increased survival at low concentrations and increased apoptosis at high concentrations, has also been observed in motor neurons and hippocampal neurons (Irie and Hirabayashi, 1998; Mitoma et al., 1998) . These observations suggest a mechanism that could reconcile the fact that p75NTR signaling causes death in certain neurons and survival in others. If p75NTR causes small increases in the amount of ceramide, survival would be enhanced, possibly through the activation of PKC. Alternatively, if p75NTR causes a large increase in ceramide concentrations, PKC would be inhibited and cells would undergo apoptosis.
A possible role for Trks
Our results show that p75NTR and ceramide are necessary components of the signaling pathway mediating BDNF-dependent survival of subplate neurons. However, the lack of effect of NGF is surprising because it implies that p75NTR alone (which binds to all neurotrophins) is not sufficient for survival; the Trks must contribute as well to endow specificity for BDNF or NT3 rather than NGF (recall that subplate neurons express TrkB and TrkC but not TrkA). Trks could activate necessary signaling pathways but only in a manner that requires little or no tyrosine kinase activity, because K252a does not block BDNF-mediated survival in our experiments. Alternatively (and in our opinion, more likely) Trks could act solely as coreceptors for p75NTR. Cotransfection experiments in A293 cells demonstrate that p75NTR can associate with both TrkB and TrkC (Bibel et al., 1999) . In other experiments, transfection of truncated TrkC (lacking the tyrosine kinase domain) into p75NTR-expressing neural crest cells resulted in NT3-specific signaling that was blocked by p75NTR-specific antibodies (Hapner et al., 1998) . This observation has been interpreted to indicate signaling through truncated TrkC, but alternatively, it could be interpreted as Trk-facilitated signaling through p75NTR.
Role of P75NTR in vivo
The in vitro results presented here suggest that p75NTR plays a role in subplate neuron survival in vivo. Consistent with this hypothesis, p75NTR expression by subplate neurons is high during the period when they are alive and functioning in cortical circuits and then is downregulated just before their death in vivo (Allendoerfer et al., 1990; Meinecke and Rakic, 1993) . Because only subplate neurons, and not cortical neurons, express p75NTR, this could be an elegant mechanism whereby one class of cortical neurons can be selectively eliminated from a cellular environment shared by all. However, preliminary experiments have not revealed an increased loss of subplate neurons in mice with the p75NTR gene knocked out (our unpublished observations), which suggests that subplate survival is controlled by multiple tropic factor receptors. One possible candidate is NT3, because, as shown in Figure 1 , subplate neurons express the NT3-specific receptor, TrkC. In support of this hypothesis, we have found that NT3-dependent subplate neuron survival in vitro is only blocked by a combination of K252a and anti-p75NTR antibodies and not by either reagent alone (our unpublished observations). Thus, whereas BDNF requires the p75NTR signaling pathway to promote survival, NT3 can signal through either Trk (likely TrkC) or p75NTR.
Although our study is of subplate neurons in vitro, these results imply that a novel p75NTR signaling pathway contributes to subplate neuron survival in vivo. Another cortical neuron population that expresses p75NTR in maturity are the basal forebrain cholinergic neurons (Woolf et al., 1989) . These neurons are dependent on p75NTR for survival and are lost in neurodegenerative diseases, such as Alzheimer's disease (Geula, 1998; Peterson et al., 1999) . Our observations here raise the possibility that these CNS neurons, like subplate neurons, use this p75NTR signaling pathway for survival in vivo. Thus, activation of this sphingolipid signaling pathway might provide a useful therapeutic approach for rescuing these neurons.
